Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company's pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Zealand Pharma.
Zealand Pharma business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Zealand Pharma are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Zealand Pharma , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Zealand Pharma including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Zealand Pharma and all latest updates of the company are provided.
The 2025 version of Zealand Pharma report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Zealand Pharma- Key Facts
2.2 Zealand Pharma- Geographic Locations
2.3 Zealand Pharma- Subsidiaries and Affiliates
2.4 Zealand Pharma- Business Divisions
2.5 Zealand Pharma- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Zealand Pharma Strategic Analysis Review
3.1 Zealand Pharma- Key Strategies
3.2 Zealand Pharma- Company Outlook Statement
3.3 Zealand Pharma- SWOT Analysis
3.3.1 Zealand Pharma- Key Strengths
3.3.2 Zealand Pharma- Key Weaknesses
3.3.3 Zealand Pharma- Potential Opportunities
3.3.4 Zealand Pharma- Potential Threats
3.4 Zealand Pharma- Key Competitors
4. Business Description of the Company
4.1 Zealand Pharma- Business Overview
4.2 Zealand Pharma- Operations by Segment
5 Products and Services Details
5.1 Zealand Pharma- Key Products
5.2 Zealand Pharma- Key Service Areas
5.3 Zealand Pharma- Key Brands
6 Company Developments
6.1 Zealand Pharma- Company History
6.2 Zealand Pharma- Latest Developments
7 Financial Analysis
7.1 Zealand Pharma- Income Statements
7.2 Zealand Pharma- Balance Sheet
7.3 Zealand Pharma- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Zealand Pharma- Direct Competitors
8.2 Zealand Pharma- Competitor Financial Ratios comparison
8.3 Zealand Pharma- Competitor Stock Charts Comparison
8.4 Zealand Pharma- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 10%
$100- 20%
$200- 10%
$100- 20%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!